Cordis Corporation, a Cardinal Health company, has pioneered less invasive treatments for vascular disease. Technological innovation and a deep understanding of the medical marketplace and the needs of patients have made Cordis the world's leading developer and manufacturer
Booth No. B02
Lunchtime Activities | |
Reengineering the Art of EVAR: Overcome Limitations of Current Stentgraft. InCraft. | |
Organized by CVRF and Supported by Educational Grant from Cardinal Health Korea Ltd. | |
Sunday, April 29 12:45 PM - 1:45 PM Room 104, Level 1 |
|
Moderator(s): Seung-Woon Rha | |
Panelist(s): Woo-Young Chung, Dong-Kie Kim, Sang Hoon Kim, Tae-Hoon Kim, Young-Guk Ko, Yoon Seok Koh, Ichihashi Shigeo | |
12:45 PM | Opening Remarks
Speaker : Seung-Woon Rha
|
12:46 PM | Experience and Benefit of InCraft Device
Lecturer : Yoon Seok Koh
|
1:00 PM | Why We Need an Ultra Low Profile Device for AAA Patient in Japan
Lecturer : Ichihashi Shigeo
|
1:15 PM | How to Overcome Limitations of Current Stentgraft
Lecturer : Young-Guk Ko
|
1:30 PM | Discussion and Q&A |
1:44 PM | Closing Remarks
Speaker : Seung-Woon Rha
|
Lunchtime Activities | |
The New Standard for High Bleeding Risk Patients:1 Month DAPT with BioFreedom¢ç | |
Organized by CVRF and Supported by Educational Grant from Cardinal Health Korea Ltd. | |
Monday, April 30 12:45 PM - 1:45 PM Room 105, Level 1 |
|
Moderator(s): Yangsoo Jang, Shigeru Nakamura | |
Panelist(s): Sungsoo Cho, Ae-Young Her, Jun-Won Lee, Gaku Nakazawa, Ha Wook Park, Jong-Pil Park | |
12:45 PM | Opening Remarks
Speaker : Yangsoo Jang
|
12:46 PM | "Who Are HBR Patients?" - Identification of HBR Patients in Clinical Practice
Lecturer : Dominick J. Angiolillo
|
12:57 PM | "How Do We Manage HBR Patients?"- Polymer-Free DES in Elderly Patients
Lecturer : Byeong-Keuk Kim
|
1:08 PM | "Biolimus A9 and Its Value"- Amazing Efficacy of Biolimus A9– Pathologic Findings
Lecturer : Gaku Nakazawa
|
1:21 PM | ¡°Clinical Outcomes with HBR¡± – LEADERS FREE JAPAN and Angioscopic Findings
Lecturer : Shimpei Nakatani
|
1:34 PM | Discussion |
1:44 PM | Closing Remarks
Speaker : Shigeru Nakamura
|